PXS 2.04% 25.0¢ pharmaxis ltd

good news on the way i think

  1. 1,175 Posts.
    lightbulb Created with Sketch. 24
    For those awaiting new trial results....

    The CF study that recruited patients in Canada and then in Argentina has reached its required number of subjects and should report either later this quarter or early next quarter, once all the subjects have completed the trial protocol.

    The investigator sponsored CF trial in the UK looking at the use of Bronchitol over a 3 month dosing period alongside Pulmozyme has also completed and PXS expecting to release data concerning by the end of the quarter.

    Let's hope the news is good.

    PXS should have a prolonged, strong recovery i think (hope!).
watchlist Created with Sketch. Add PXS (ASX) to my watchlist
(20min delay)
Mkt cap ! $98.66M
Open High Low Value Volume
24.5¢ 25.5¢ 24.5¢ $69.28K 277.6K

Buyers (Bids)

No. Vol. Price($)
1 43786 25.0¢

Sellers (Offers)

Price($) Vol. No.
26.0¢ 55000 2
View Market Depth
Last trade - 16.10pm 05/12/2019 (20 minute delay) ?
0.005 ( 2.00 %)
Open High Low Volume
24.8¢ 25.5¢ 24.8¢ 72284
Last updated 15.28pm 05/12/2019 (live) ?
PXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.